Join to View Full Profile
500 W San Bernardino RdSte BCovina, CA 91722
Phone+1 626-960-2326
Fax+1 626-960-9796
Dr. Arora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sartaj Arora is a gastroenterologist based in Covina, CA, with specialized experience in hepatic cirrhosis, flexible sigmoidoscopy, percutaneous endoscopic gastrostomy placement, biliary tract disease, and esophageal disease. He completed his medical education and training at the University of California San Diego School of Medicine, Los Angeles County-Harbor-UCLA Medical Center, and UCLA David Geffen School of Medicine/UCLA Medical Center. He is currently employed at Suresht Paul Sharma MD Inc and has participated in multiple clinical trials related to ulcerative colitis and Crohn's disease. Dr. Arora received the CMS Meaningful Use Stage 1 Certification from NextGen Ambulatory EHR in 2012-2013.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2002 - 2005
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1999 - 2002
University of California San Diego School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2026
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
- A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) Start of enrollment: 2017 Jan 31
- A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 Start of enrollment: 2018 Mar 21
- Join now to see all
Other Languages
- Spanish, Hindi, Punjabi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
